Dopamine Beta Hydroxylase (Dbh) Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
DBH neurons are noradrenergic neurons that convert dopamine to norepinephrine via the enzyme dopamine beta-hydroxylase. These neurons constitute the major source of norepinephrine in the central nervous system and play critical roles in arousal, attention, stress response, and autonomic function. [1]
| Property | Value | [2]
|----------|-------| [3]
| Category | Catecholamine Neurons | [4]
| Location | Locus coeruleus, Brainstem | [5]
| Enzyme | Dopamine beta-hydroxylase |
| Transmitter | Norepinephrine |
| Gene | DBH |
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000169 | type B pancreatic cell |
| Database | ID | Name | Confidence |
|---|---|---|---|
| Cell Ontology | CL:0000169 | type B pancreatic cell | Medium |
The locus coeruleus (LC) is the primary noradrenergic nucleus in the brain:
| Cell Group | Location | Projection |
|---|---|---|
| A1 | Ventrolateral medulla | Spinal cord |
| A2 | Nucleus tractus solitarius | Hypothalamus |
| A5 | Pontine tegmentum | Spinal cord |
| A7 | Lateral pontine tegmentum | Spinal cord |
The DBH enzyme catalyzes the conversion of dopamine to norepinephrine:
Norepinephrine acts through:
α1-adrenergic receptors: Gq-coupled, excitatory
α2-adrenergic receptors: Gi-coupled, inhibitory
β-adrenergic receptors: Gs-coupled, excitatory### Cognitive Functions
Attention:
LC-norepinephrine system enhances signal-to-noise ratio
The locus coeruleus is one of the earliest sites of tau pathology:
Noradrenergic dysfunction contributes to both motor and non-motor symptoms:
| Target | Drug Class | Application |
|---|---|---|
| α2 receptors | Agonists | ADHD, depression |
| α1 antagonists | Prazosin | PTSD, hypertension |
| β blockers | Propranolol | Anxiety, performance |
The study of Dopamine Beta Hydroxylase (Dbh) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[Kaufman, DBH enzyme biochemistry (1987)](https://doi.org/10.1016/0006-291X(87). 1987. ↩︎
Chalermpalanupap et al. LC dysfunction in AD (2013). 2013. ↩︎
Espay et al. Noradrenergic deficits in PD (2014). 2014. ↩︎